Found: 68
Select item for more details and to access through your institution.
Impact of maintenance therapy following induction immunochemotherapy for untreated advanced non-small cell lung cancer patients.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 11, p. 2985, doi. 10.1007/s00432-021-03866-2
- By:
- Publication type:
- Article
Early discontinuation of induction therapy in chemoimmunotherapy as an effective alternative to the standard regimen in patients with non-small cell lung cancer: a retrospective study.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2022, v. 148, n. 9, p. 2437, doi. 10.1007/s00432-021-03782-5
- By:
- Publication type:
- Article
Efficacy and safety of first-line pembrolizumab monotherapy in elderly patients (aged ≥ 75 years) with non-small cell lung cancer.
- Published in:
- Journal of Cancer Research & Clinical Oncology, 2020, v. 146, n. 2, p. 457, doi. 10.1007/s00432-019-03072-1
- By:
- Publication type:
- Article
First reported case of hemoglobin lansing in Asia detected by false low oxygen saturation on pulse oximetry.
- Published in:
- 2012
- By:
- Publication type:
- Letter
Endocrinopathies Associated with Immune Checkpoint Inhibitor Cancer Treatment: A Review.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 7, p. 2033, doi. 10.3390/jcm9072033
- By:
- Publication type:
- Article
Final Results from a Phase II Trial of Osimertinib for Elderly Patients with Epidermal Growth Factor Receptor t790m-Positive Non-Small Cell Lung Cancer That Progressed during Previous Treatment.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1762, doi. 10.3390/jcm9061762
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors for Lung Cancer Treatment: A Review.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 5, p. 1362, doi. 10.3390/jcm9051362
- By:
- Publication type:
- Article
Retrospective Efficacy Analysis of Immune Checkpoint Inhibitor Rechallenge in Patients with Non-Small Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 1, p. 102, doi. 10.3390/jcm9010102
- By:
- Publication type:
- Article
Phase I/II Study of Docetaxel and S-1 in Previously-Treated Patients with Advanced Non-Small Cell Lung Cancer: LOGIK0408.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2196, doi. 10.3390/jcm8122196
- By:
- Publication type:
- Article
Association of Sarcopenia with and Efficacy of Anti-PD-1/PD-L1 Therapy in Non-Small-Cell Lung Cancer.
- Published in:
- Journal of Clinical Medicine, 2019, v. 8, n. 4, p. 450, doi. 10.3390/jcm8040450
- By:
- Publication type:
- Article
Information-Sharing System for Disaster Recovery of Dialysis Therapy in Japan.
- Published in:
- Biomedical Instrumentation & Technology, 2009, v. 43, n. 1, p. 70, doi. 10.2345/0899-8205-43.1.70
- By:
- Publication type:
- Article
Chronic Pseudomonas aeruginosa infection-induced chronic bronchitis and emphysematous changes in CCSP-deficient mice.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 2321, doi. 10.2147/COPD.S113707
- By:
- Publication type:
- Article
Critical role of tumor necrosis factor receptor 1 in the pathogenesis of pulmonary emphysema in mice.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 1705, doi. 10.2147/COPD.S108919
- By:
- Publication type:
- Article
Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab.
- Published in:
- Internal Medicine, 2021, v. 60, n. 22, p. 3585, doi. 10.2169/internalmedicine.7219-21
- By:
- Publication type:
- Article
Phase I study of S-1 plus paclitaxel combination therapy as a first-line treatment in elderly patients with advanced non-small cell lung cancer.
- Published in:
- Investigational New Drugs, 2019, v. 37, n. 2, p. 291, doi. 10.1007/s10637-018-0656-z
- By:
- Publication type:
- Article
Nab-paclitaxel maintenance therapy following carboplatin + nab-paclitaxel combination therapy in chemotherapy naïve patients with advanced non-small cell lung cancer: multicenter, open-label, single-arm phase II trial.
- Published in:
- Investigational New Drugs, 2018, v. 36, n. 5, p. 903, doi. 10.1007/s10637-018-0617-6
- By:
- Publication type:
- Article
Rationale and Design of a Phase II Trial of Osimertinib Combined With Bevacizumab in Patients With Untreated Epidermal Growth Factor Receptor-mutated Non-small-cell Lung Cancer and Malignant Pleural and/or Pericardial Effusion (SPIRAL II Study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920927841
- By:
- Publication type:
- Article
Species D Human Adenovirus Type 9 Exhibits Better Virus-Spread Ability for Antitumor Efficacy among Alternative Serotypes.
- Published in:
- PLoS ONE, 2014, v. 9, n. 2, p. 1, doi. 10.1371/journal.pone.0087342
- By:
- Publication type:
- Article
Safety and Usefulness of Cryobiopsy and Stamp Cytology for the Diagnosis of Peripheral Pulmonary Lesions.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 410, doi. 10.3390/cancers11030410
- By:
- Publication type:
- Article
Clinical Characteristics of Osimertinib Responder in Non-Small Cell Lung Cancer Patients with EGFR-T790M Mutation.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 365, doi. 10.3390/cancers11030365
- By:
- Publication type:
- Article
Tumor Neovascularization and Developments in Therapeutics.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 316, doi. 10.3390/cancers11030316
- By:
- Publication type:
- Article
Nicotine Induces Resistance to Erlotinib Therapy in Non-Small-Cell Lung Cancer Cells Treated with Serum from Human Patients.
- Published in:
- Cancers, 2019, v. 11, n. 3, p. 282, doi. 10.3390/cancers11030282
- By:
- Publication type:
- Article
Comparison of Body Fluid Volumes Determined by Kinetic Modeling and by Bioimpedance Spectroscopy.
- Published in:
- Blood Purification, 2022, v. 51, n. 10, p. 866, doi. 10.1159/000521563
- By:
- Publication type:
- Article
Mutational Profile Evaluates Response and Survival to First‐Line Chemotherapy in Lung Cancer.
- Published in:
- Advanced Science, 2021, v. 8, n. 4, p. 1, doi. 10.1002/advs.202003263
- By:
- Publication type:
- Article
Prophylactic treatment of dacomitinib‐induced skin toxicities in epidermal growth factor receptor‐mutated non–small‐cell lung cancer: A multicenter, Phase II trial.
- Published in:
- Cancer Medicine, 2023, v. 12, n. 14, p. 15117, doi. 10.1002/cam4.6184
- By:
- Publication type:
- Article
Retrospective efficacy analysis of immune checkpoint inhibitors in patients with EGFR‐mutated non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2019, v. 8, n. 4, p. 1521, doi. 10.1002/cam4.2037
- By:
- Publication type:
- Article
Advanced Non-Small-Cell Lung Cancer in Elderly Patients: Patient Features and Therapeutic Management.
- Published in:
- BioMed Research International, 2018, v. 2018, p. 1, doi. 10.1155/2018/8202971
- By:
- Publication type:
- Article
Editorial: Treatment for Non-Small Cell Lung Cancer in Distinct Patient Populations.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.838570
- By:
- Publication type:
- Article
The Impact of VEGF Inhibition on Clinical Outcomes in Patients With Advanced Non-Small Cell Lung Cancer Treated With Immunotherapy: A Retrospective Cohort Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.663612
- By:
- Publication type:
- Article
Immune-Related Adverse Events Are Associated With Clinical Benefit in Patients With Non-Small-Cell Lung Cancer Treated With Immunotherapy Plus Chemotherapy: A Retrospective Study.
- Published in:
- Frontiers in Oncology, 2021, v. 11, p. N.PAG, doi. 10.3389/fonc.2021.630136
- By:
- Publication type:
- Article
Infectivity enhanced, hTERT promoter-based conditionally replicative adenoviruses are useful for SCLC treatment.
- Published in:
- Cancer Gene Therapy, 2005, v. 12, n. 9, p. 737, doi. 10.1038/sj.cgt.7700838
- By:
- Publication type:
- Article
Comprehensive Kinase Activity Profiling Revealed the Kinase Activity Patterns Associated with the Effects of EGFR Tyrosine Kinase Inhibitor Therapy in Advanced Non-Small-Cell Lung Cancer Patients with Sensitizing EGFR Mutations.
- Published in:
- Proteomes, 2023, v. 11, n. 1, p. 6, doi. 10.3390/proteomes11010006
- By:
- Publication type:
- Article
Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 10, p. 2867, doi. 10.1111/1759-7714.13622
- By:
- Publication type:
- Article
Serum immune modulators during the first cycle of anti‐PD‐1 antibody therapy in non‐small cell lung cancer: Perforin as a biomarker.
- Published in:
- Thoracic Cancer, 2020, v. 11, n. 11, p. 3223, doi. 10.1111/1759-7714.13650
- By:
- Publication type:
- Article
Prognostic impact of pleural effusion in EGFR‐mutant non‐small cell lung cancer patients without brain metastasis.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 557, doi. 10.1111/1759-7714.12979
- By:
- Publication type:
- Article
Impact of bowel movement condition on immune checkpoint inhibitor efficacy in patients with advanced non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2019, v. 10, n. 3, p. 526, doi. 10.1111/1759-7714.12969
- By:
- Publication type:
- Article
The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Efficacy and safety of immune checkpoint inhibitor monotherapy in pretreated elderly patients with non-small cell lung cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients.
- Published in:
- Scientific Reports, 2020, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41598-020-74573-0
- By:
- Publication type:
- Article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features.
- Published in:
- NPJ Precision Oncology, 2022, v. 6, n. 1, p. 1, doi. 10.1038/s41698-021-00250-8
- By:
- Publication type:
- Article
The role of clinical engineers in dialysis therapy in Japan.
- Published in:
- Renal Replacement Therapy, 2024, v. 10, n. 1, p. 1, doi. 10.1186/s41100-023-00513-z
- By:
- Publication type:
- Article
Shared decision making for the initiation and continuation of dialysis: a proposal from the Japanese Society for Dialysis Therapy.
- Published in:
- Renal Replacement Therapy, 2021, v. 7, n. 1, p. 1, doi. 10.1186/s41100-021-00365-5
- By:
- Publication type:
- Article
364. Prevention of Radiation Pneumonitis by Recombinant Adenovirus-Mediated Transfer of Soluble TGF-βtype II Receptor Gene
- Published in:
- 2005
- By:
- Publication type:
- Abstract
322. Tumor Specific Activation of Irinotecan by a Carboxylesterase Fused with Anti CEA scFv
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Prognostic Nutritional Index and Lung Immune Prognostic Index as Prognostic Predictors for Combination Therapies of Immune Checkpoint Inhibitors and Cytotoxic Anticancer Chemotherapy for Patients with Advanced Non-Small Cell Lung Cancer.
- Published in:
- Diagnostics (2075-4418), 2022, v. 12, n. 2, p. 423, doi. 10.3390/diagnostics12020423
- By:
- Publication type:
- Article
Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: Results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Elevation of serum C-reactive protein predicts failure of the initial antimicrobial treatment for febrile neutropenia with lung cancer.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2013, v. 19, n. 2, p. 202, doi. 10.1007/s10156-012-0474-8
- By:
- Publication type:
- Article
The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma.
- Published in:
- Journal of Infection & Chemotherapy (Springer Science & Business Media B.V.), 2012, v. 18, n. 5, p. 668, doi. 10.1007/s10156-012-0391-x
- By:
- Publication type:
- Article